Results 1 to 10 of about 1,264,142 (360)

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment

Journal of Patient-Reported Outcomes, 2021
Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland, Rhea Racho, Maureen Kamischke, Kate Moraras, Evangeline Wang, Chari Cohen, Stuart Kendrick   +6 more
doaj   +1 more source

Awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign

BMC Gastroenterology, 2022
Introduction In 2016 the World Health Organization (WHO) had adopted a global strategy to eliminate Hepatitis B (HBV) by 2030 through five core interventions.
Zhuo-zhi Lim, Jau shya Teo, Ah-Choon Tan, Teck Onn Lim   +3 more
doaj   +1 more source

The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?

Archives of Public Health, 2021
Background Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC).
Tomoyuki Hayashi, Yumie Takeshita, Yvan J.-F. Hutin, Hande Harmanci, Philippa Easterbrook, Sarah Hess, Judith van Holten, Ena Oghenekaro Oru, Shuichi Kaneko, Cihan Yurdaydin, Marc Bulterys   +10 more
doaj   +1 more source

Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination [PDF]

Journal of Preventive Medicine and Public Health, 2021
Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or ...
Nathalie Brunner, Philip Bruggmann
doaj   +1 more source

Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study

BMC Public Health, 2021
Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland, Sean Farrell, Priyanka Kumar, Maureen Kamischke, Michaela Jackson, Sierra Bodor, Timothy M. Block, Rosemary Frasso, Chari Cohen   +8 more
doaj   +1 more source

Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project

Harm Reduction Journal, 2022
Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts.
Julia A. Silano, Carla Treloar, Kyle Leadbeatter, Sandy Davidson, Justine Doidge   +4 more
doaj   +1 more source

P-117 LOW PREVALENCE OF HEPATITIS B AND C AMONG PEOPLE LIVING IN POVERTY IN NORTHEAST BRAZIL

Annals of Hepatology, 2021
Introduction: Hepatitis B and C infection are responsible for more than 300 million of chronic liver disease patients all over the world. One goal of WHO 2030 agenda is the eradication of hepatitis B and C.
Livia Melo Villar, Aline Borges Cardoso, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Julia Trece Marques, Giselle Prado do Nascimento, Barbara Vieira do Lago   +6 more
doaj   +1 more source

P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL

Annals of Hepatology, 2021
Introduction: Pregnant women are considered more vulnerable to viral infections, such as severe viral respiratory infections and viral hepatitis. Data about Brazilian pregnant and postpartum women found a case fatality rate of 12.7% among COVID-19 Acute ...
Alanna Calheiros Santos, Vanessa Salete de Paula, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Laura Cristina Machado Pinto, Lia Laura Lewis-Ximenez, Livia Melo Villar   +6 more
doaj   +1 more source

Prevention, testing, and treatment interventions for hepatitis B and C in refugee populations: results of a scoping review

BMC Infectious Diseases, 2023
Background and aims Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment.
Ankeeta Saseetharran, Lindsey Hiebert, Neil Gupta, Françoise Nyirahabihirwe, Innocent Kamali, John W. Ward   +5 more
doaj   +1 more source

P-98 BIOCHEMICAL MAKERS AMONG CHRONIC LIVER DISEASE PATIENTS ACCORDING COVID-19 INFECTION: A FOLLOW-UP STUDY

Annals of Hepatology, 2021
Introduction: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly around the world, posing a major threat to human health and the economy.
Lucas Lima da Silva, Alanna Calheiros Santos, Fabiola Justina Fumero Leon, Vanessa Duarte da Costa, Juliana Custódio Miguel, Julia Trece Marques, Giselle Prado do Nascimento, Elisangela Ferreira da Silva, Lia Laura Lewis-Ximenez, Vanessa Salete de Paula, Livia Melo Villar   +10 more
doaj   +1 more source